CompuGroup Medical Societas Europaea develops and sells software and information technology services for healthcare sector worldwide. The company's Ambulatory Information Systems segment provides practice management software and electronic medical records for office-based physicians, dentists, medical care centers, and physician's networks.
Read More…
Industry, Sector and Symbol
Industry Health Information Services
Sub-IndustryN/A
SectorComputer and Technology
CIKN/A
Phone+49-261-80000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$741.61 million
Profitability
Miscellaneous
Employees5,000
Next Earnings Date11/7/2019 (Estimated)
OptionableOptionable
Compugroup Medical (ETR:COP) Frequently Asked Questions
What is Compugroup Medical's stock symbol?
Compugroup Medical trades on the ETR under the ticker symbol "COP."
When is Compugroup Medical's next earnings date?
What price target have analysts set for COP?
8 analysts have issued 12 month price targets for Compugroup Medical's stock. Their predictions range from €40.00 to €70.00. On average, they expect Compugroup Medical's stock price to reach €57.75 in the next year. This suggests a possible upside of 2.0% from the stock's current price. View Analyst Price Targets for Compugroup Medical.
What is the consensus analysts' recommendation for Compugroup Medical?
8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Compugroup Medical in the last year. There are currently 1 sell rating, 4 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Compugroup Medical.
Has Compugroup Medical been receiving favorable news coverage?
News coverage about COP stock has trended somewhat negative on Saturday, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Compugroup Medical earned a media sentiment score of -1.5 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for Compugroup Medical.
Who are some of Compugroup Medical's key competitors?
Some companies that are related to Compugroup Medical include 10x Genomics (TXG), Pro Medicus (PME), Craneware (CRW), Alcidion Group (ALC), Sensyne Health (SENS), Mach7 Technologies (M7T), Kneat.com (KSI), Medadvisor (MDR), Reliq Health Technologies (RHT), Oneview Healthcare (ONE), CogState (CGS), Induction Healthcare Group (INHC), Vitalhub (VHI), 1ST Group (1ST) and ICSGlobal (ICS).
What other stocks do shareholders of Compugroup Medical own?
Who are Compugroup Medical's key executives?
Compugroup Medical's management team includes the folowing people:
- Mr. Frank Gotthardt, Chairman of Management Board & CEO (Age 69)
- Mr. Christian Bartlett Teig, CFO & Member of Management Board (Age 54)
- Mr. Uwe Eibich, Exec. VP of Telematics & eHealth Platforms and Member of Management Board (Age 57)
- Mr. Hannes Reichl, Member of Exec. Board
- Mr. Frank Brecher, Chief Process Officer & Member of Management Board (Age 49)
What is Compugroup Medical's stock price today?
One share of COP stock can currently be purchased for approximately €56.60.
How big of a company is Compugroup Medical?
What is Compugroup Medical's official website?
How can I contact Compugroup Medical?
Compugroup Medical's mailing address is Maria Trost 21, KOBLENZ, 56070, Germany. The company can be reached via phone at +49-261-80000.
MarketBeat Community Rating for Compugroup Medical (ETR COP)
MarketBeat's community ratings are surveys of what our community members think about Compugroup Medical and other stocks. Vote "Outperform" if you believe COP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe COP will underperform the S&P 500 over the long term. You may vote once every thirty days.
